Defendant Profile · Healthcare
Blood Pressure Drug Settlement -- $15.26M for Contaminated Valsartan, Losartan, Irbesartan
Quick answer
Blood Pressure Drug Settlement -- $15.26M for Contaminated Valsartan, Losartan, Irbesartan has a Corp-Watch grade of A+ based on 1 tracked class action settlements in the Healthcare industry.
Corporate Responsibility Matrix
Independent trust score from class action track record
A+93/100
A+
A
B
C
D
F
Active suits
0
Total public payouts
$0M
Avg distribution velocity
Insufficient data
Class action score100% weight
93/100
Updated Not yet computed. Methodology. Editorial grade — not legal advice.
Tracked cases against this defendant
Defendant FAQ
Questions about Blood Pressure Drug Settlement -- $15.26M for Contaminated Valsartan, Losartan, Irbesartan
- Corp-Watch grades (A+ through F) reflect litigation volume, payout pools, distribution timelines, and public regulatory signals. Grades refresh automatically every six hours.